PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
Company to initiate Phase 3 VERSATILE-003 trial in Q4 2024 Conference Call Today at 8:00 a.m. Eastern Time PRINCETON, N.J.,...
Clinical Trial
Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations
Company announces appointments of Dr. Claudio Dansky Ullmann as CMO and Ms. Karen Andreas as VP, Clinical Operations Appointments support...
Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024
Webcast and Conference Call To be Held Tuesday, August 6, 2024, 8:30 am ETNEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE)...
Kura Oncology to Report Second Quarter 2024 Financial Results
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
End-of-treatment data presented at the EASL Congress from two Phase 2a clinical trials supports advancing imdusiran as a potential cornerstone...
MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory
VANCOUVER, BC / ACCESSWIRE / August 1, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical...
Glaukos Announces Second Quarter 2024 Financial Results
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the...
Glaukos Announces Second Quarter 2024 Financial Results
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the...
Smart Wearable Healthcare Devices Market size is set to grow by USD 24.22 billion from 2024-2028, Increasing focus on patient engagement boost the market, Technavio
NEW YORK, July 31, 2024 /PRNewswire/ -- The global smart wearable healthcare devices market size is estimated to grow by USD 24.22...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 31, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release...
Writer Releases State-of-the-Art Specialized LLMs to Revolutionize Healthcare and Financial Services AI Applications
#1 Benchmarked Palmyra-Med-70b and Palmyra-Fin-70b now available as open models on NVIDIA API catalog, Baseten, and Hugging Face, empowering developers...
FloraWorks Announces Peer-Reviewed Publication of Groundbreaking Sleep Study on TruCBN(TM)
TruCBN(TM) is the first cannabinoid proven to be a safe and effective sleep aid in the largest blinded, randomized, placebo-controlled...
Sona Nanotech to Arrange Private Placement Financing
Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is...
inPhronesis Announces Name Change to inThought Labs
The new name highlights the combined capabilities of decision support expertise and advanced technology solutions ORLANDO, Fla., July 30, 2024...
Clinical Trial Management System (CTMS) Market size is set to grow by USD 1.86 billion from 2024-2028, Increasing healthcare expenditure to boost the market growth, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ -- The global clinical trial management system (CTMS) market size is estimated to grow by...
Agilisium Achieves AWS Life Sciences Competency Status
LOS ANGELES, July 30, 2024 /PRNewswire/ -- Agilisium, a pioneering leader in Data Analytics, Cloud, and Life Science solutions, today announced...
eClinical Solutions Market worth $22.1 billion by 2029 driven by Rising Chronic Illness Rates | MarketsandMarkets™
CHICAGO, July 30, 2024 /PRNewswire/ -- The global eClinical Solutions Market is expected to grow from USD 11.6 billion in 2024...
Slope Appoints Jim Munz as Chief Product & Technology Officer
Former Veeva and ERT clinical trial technology executive will drive strategy towards a complete, tech-enabled biospecimen lifecycle solution RICHMOND, Va.,...
Next Presentation in Record-Breaking Sleep Apnea Webinar Series Announced
Live presentations by leading sleep researchers available globally to front-line clinicians MURFREESBORO, Tenn., July 30, 2024 /PRNewswire/ -- SleepWorld Magazine...
Chemomab Therapeutics Announces Closing of $10 Million Private Placement
— HBM Healthcare Investments, OrbiMed and Sphera Biotech Master Fund LP Participated in the Financing that Extends Cash Runway Potentially...